WHEN SHOULD A SHARING PLATFORM ADOPT THE BILATERAL REVIEW SYSTEM?

Autor: Xuanqi Chen chenxuanqi@stu.xjtu.edu.cn, Gang Li glee@mail.xjtu.edu.cn, Shengli Li lishengli@pku.edu.cn, Quan Zheng benzheng@ustc.edu.cn

Publikováno v: MIS Quarterly. Sep2024, Vol. 48 Issue 3, p1121-1155. 35p. 3 Diagrams, 2 Charts.

The Influence of Shared Consumption on Product Efficacy Perceptions: The Detrimental Effect of Sharing with Strangers.

Autor: Lteif, Lama (AUTHOR), Block, Lauren (AUTHOR), Kramer, Thomas (AUTHOR) thomas.kramer@ucr.edu, Hada, Mahima (AUTHOR)

Publikováno v: Journal of Marketing Research (JMR). Jun2024, Vol. 61 Issue 3, p536-551. 16p.

Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.

Autor: Chua KP; Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. chuak@med.umich.edu.; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA. chuak@med.umich.edu., Conti RM; Department of Markets, Public Policy, And Law, Questrom School of Business, Boston University, Boston, MA, USA., Lagisetty P; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Bohnert ASB; Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA., Nuliyalu U; Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Nguyen TD; Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Sep; Vol. 39 (12), pp. 2160-2168. Date of Electronic Publication: 2024 Jun 18.

Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.

Autor: Mehmandoost S; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Khezri M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA., Aghaali N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Shokoohi M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON, Canada., Haghdoost AA; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Tavakoli F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA., Karamouzian M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV, Surveillance Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. mohammad.karamouzian@unityhealth.to.; Centre on Drug Policy Evaluation, Saint Michael's Hospital, Toronto, ON, Canada. mohammad.karamouzian@unityhealth.to.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. mohammad.karamouzian@unityhealth.to.

Publikováno v: Harm reduction journal [Harm Reduct J] 2024 Oct 18; Vol. 21 (1), pp. 187. Date of Electronic Publication: 2024 Oct 18.

Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA.

Autor: Killion JA; University of California San Diego, CA, USA; San Diego State University, CA, USA. Electronic address: jakillion@ucsd.edu., Jegede OS; University of California San Diego, CA, USA; San Diego State University, CA, USA., Werb D; University of California San Diego, CA, USA; Centre on Drug Policy Evaluation, St. Michael's Hospital, Toronto, Canada., Davidson PJ; University of California San Diego, CA, USA., Smith LR; University of California San Diego, CA, USA., Gaines T; University of California San Diego, CA, USA., Graff Zivin J; University of California San Diego, CA, USA., Zúñiga ML; San Diego State University, CA, USA., Pines HA; University of California San Diego, CA, USA; San Diego State University, CA, USA., Garfein RS; University of California San Diego, CA, USA., Strathdee SA; University of California San Diego, CA, USA., Rivera Saldana C; University of California San Diego, CA, USA., Martin NK; University of California San Diego, CA, USA; University of Bristol, Bristol, UK.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2024 Oct; Vol. 132, pp. 104557. Date of Electronic Publication: 2024 Aug 29.